Sinovac 4Q earnings show busy China FDA trial calendar; PPD opens Shanghai lab;

> Sinovac's 4Q earnings report shows a busy clinical trials calendar with China FDA. Release

> PPD Laboratories announced the opening of a central lab in Shanghai "equipped with cutting-edge analytical equipment to provide high-quality data across a wide range of technologies and applications for all phases of pharmaceutical development." Release

> Eisai and Arena Pharmaceuticals ($ARNA) completed registration trials for a release formulation of Lorcaserin. Release

> Taiwan's TWi Pharmaceuticals says its U.S. unit has sales licenses from all 50 states. Release

> Baxter ($BAX) submitted BAX 855 to Japan's MHLW for approval. Release

> Singapore's A*STAR Genome Institute found a genetic cause for the prevalence of psoriasis among Caucasians over Chinese. Release

Read more on